↓ Skip to main content

Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience

Overview of attention for article published in BMC Gastroenterology, April 2014
Altmetric Badge

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience
Published in
BMC Gastroenterology, April 2014
DOI 10.1186/1471-230x-14-80
Pubmed ID
Authors

Satoshi Yamada, Takuya Yoshino, Minoru Matsuura, Naoki Minami, Takahiko Toyonaga, Yusuke Honzawa, Yoshihisa Tsuji, Hiroshi Nakase

Abstract

The long-term efficacy of infliximab (IFX) for patients with refractory ulcerative colitis (UC) is unclear. The aim of this study was to assess the long-term outcomes of IFX treatment in patients with refractory UC.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 15%
Student > Bachelor 6 11%
Other 5 9%
Student > Ph. D. Student 4 7%
Student > Postgraduate 4 7%
Other 12 22%
Unknown 15 28%
Readers by discipline Count As %
Medicine and Dentistry 20 37%
Agricultural and Biological Sciences 5 9%
Computer Science 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Mathematics 1 2%
Other 5 9%
Unknown 17 31%